Kong D, Li Y, Fu C, Hou M, et al. Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia. Leuk Lymphoma 2021 Oct 20:1-4. doi: 10.1080/10428194.2021.1992766.
PMID: 34668450